AFLD 2013 FFA vs Respondent M35

Facts
The French Athletics Federation (Fédération Française d'athlétisme, FFA) charges respondent M35 for a violation of the Anti-Doping Rules. During a doping controls organized at August 3 and 5, 2012, the respondent provided a sample for doping test. The sample tested positive on erythropoietin which is a prohibited substance on the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had been positive on a previous doping test on January 20, 2011, for the substance Growth Hormone Releasing Peptide (GHRP).

Decision
1. The sanction is a period of ineligibility of 2 years in which the respondent can't take part to participate organized sports competitions and events authorized by French sports federations.
2. Deduction of the period of ineligibility with the period of voluntary suspension.
3. The decision starts on the date of the notification.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
28 March 2013
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Second violation
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération française d'athlétisme (FFA) - French Athletics Federation
Laboratories
Cologne, Germany: Institute of Biochemistry - German Sport University Cologne
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Analytical aspects
B sample analysis
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Erythropoietin (EPO)
Document type
Pdf file
Date generated
20 January 2014
Date of last modification
2 June 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin